In HPV-associated Oropharyngeal Cancer, Cisplatin-based Chemoradiotherapy is superior to Cetuximab-based Bioradiotherapy in Terms of Overall Survival

被引：0
|
作者：
Semrau, Sabine [1 ]
机构：
[1] Univ Strahlenklin, Univ Str 27, D-91054 Erlangen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷 / 05期
关键词：
D O I：
10.1007/s00066-019-01441-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：447 / 449
页数：3
相关论文
共 50 条
  • [1] Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers
    Monali Swain
    Tejpal Gupta
    Sadhana Kannan
    JaiPrakash Agarwal
    [J]. European Archives of Oto-Rhino-Laryngology, 2019, 276 : 2111 - 2112
  • [2] Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers
    Swain, Monali
    Gupta, Tejpal
    Kannan, Sadhana
    Agarwal, JaiPrakash
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (07) : 2111 - 2112
  • [3] Beim HPV-assoziierten Oropharynxkarzinom ist die Radiochemotherapie mit Cisplatin der Bioradiotherapie mit Cetuximab in Bezug auf das Gesamtüberleben überlegenIn HPV-associated oropharyngeal cancer, chemoradiotherapy with cisplatin is superior to bioradiotherapy with cetuximab in terms of overall survival
    Sabine Semrau
    [J]. Strahlentherapie und Onkologie, 2019, 195 (5) : 447 - 449
  • [4] Concurrent cisplatin-based chemoradiotherapy versus cetuximab-based bioradiotherapy for p16-positive, locally advanced oropharyngeal cancer: A meta-analysis
    Suton, P.
    Skelin, M.
    Luksic, I.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Comparison of high-dose Cisplatin-based chemoradiotherapy and Cetuximab-based bioradiotherapy for p16-positive oropharyngeal squamous cell carcinoma in the context of revised HPV-based staging
    Bhattasali, Onita
    Thompson, Lester D. R.
    Abdalla, Iman A.
    Chen, Jergin
    Iganej, Shawn
    [J]. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2018, 23 (05) : 451 - 457
  • [6] Concurrent Cetuximab-based bioradiotherapy versus Cisplatin-based Chemoradiotherapy in the Definitive Management of Favourable Biology Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma: Systematic Review and Meta-analysis
    Swain, M.
    Kannan, S.
    Srinivasan, S.
    Agarwal, J. P.
    Gupta, T.
    [J]. CLINICAL ONCOLOGY, 2022, 34 (12) : 786 - 795
  • [7] Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Petar Suton
    Marko Skelin
    Zoran Rakusic
    Stjepan Dokuzovic
    Ivica Luksic
    [J]. European Archives of Oto-Rhino-Laryngology, 2019, 276 : 1275 - 1281
  • [8] Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Suton, Petar
    Skelin, Marko
    Rakusic, Zoran
    Dokuzovic, Stjepan
    Luksic, Ivica
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (05) : 1275 - 1281
  • [9] Decreased overall survival in black patients with HPV-associated oropharyngeal cancer
    Sheth, Siddharth
    Farquhar, Douglas R.
    Lenze, Nicholas R.
    Mazul, Angela
    Brennan, Paul
    Anantharaman, Devasena
    Abedi-Ardekani, Behnoush
    Zevallos, Jose P.
    Hayes, D. Neil
    Olshan, F.
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 42 (01)
  • [10] Hearing Outcomes in Cisplatin or Cetuximab Combined with Radiation for Patients with HPV-Associated Oropharyngeal Cancer in NRG/RTOG 1016
    Runge, C. L.
    Lyness, J.
    Gillison, M.
    Adelstein, D. J.
    Harari, P. M., Jr.
    Ringash, J. G.
    Geiger, J. L.
    Krempl, G. A.
    Blakaj, D.
    Bates, J.
    Galloway, T. J.
    Jones, C. U.
    Gensheimer, M.
    Dunlap, N. E.
    Phan, J.
    Caudell, J.
    Pennington, D.
    Torres-Saavedra, P.
    Yom, S. S.
    Le, Q. T.
    Movsas, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S122 - S123
12345